Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin/Hematocrit
Status:
Recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
This multi-center, prospective study will evaluate the use of topical tranexamic acid (TXA -
Cyklokapron; Pfizer, New York, NY) on pre-operative and post-operative hemoglobin
(Hb)/hematocrit (Hct) in patients undergoing operative repair of isolated posterior wall (PW)
acetabular fractures.